Loading…
Dipna Pharmachem (BSE 543594)₹4.14−3.94%Pharmaceuticals
Dipna Pharmachem is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 4.2 against a peer median of 22.3, and ROCE of 8.1% against a peer median of 6.6%, and latest-quarter sales growth of −87.2% against a peer median of −8.8%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Centuple Global | 18 | 11.6 | 15.0 | 12.7 | 0.29 | 0.0 | 575 | 2 | 1,07,642.3 | −1,040.0 | vs BSE 543594 |
| Colinz Laboratories | 18 | 6.4 | 7.2 | 5.3 | 0.04 | 0.0 | 6 | 1 | −21.2 | 1,753.8 | vs BSE 543594 |
| Zenith Health Care | 17 | — | 0.3 | 0.1 | 0.00 | 0.0 | 10 | 0 | −23.7 | −430.0 | vs BSE 543594 |
| Starsource Multitrade | 17 | — | −163.9 | −164.0 | 0.00 | 0.0 | 1 | −12 | — | — | vs BSE 543594 |
| Desh Rakshak Aushdhalaya | 14 | 22.3 | 6.6 | 4.9 | 0.21 | 0.0 | 7 | 1 | −21.5 | −17.1 | vs BSE 543594 |
| Beryl Drugs | 13 | 31.1 | 7.2 | 4.3 | 0.25 | 0.0 | 19 | 0 | 4.8 | 292.9 | vs BSE 543594 |
| Unjha Formulations | 13 | 26.7 | 27.7 | 20.1 | 0.00 | 0.0 | 16 | 1 | −8.8 | −57.5 | vs BSE 543594 |
| ORTIN GLOBAL | 11 | — | −32.1 | −46.0 | 0.81 | 0.0 | 0 | −1 | 262.5 | — | vs BSE 543594 |
| Dipna Pharmachem | 11 | 4.2 | 8.1 | 5.3 | 0.21 | 0.0 | 129 | 3 | −87.2 | −62.7 | — |
| Adline Chem Lab | 9 | — | −933.4 | — | — | 0.0 | 0 | −0 | — | −145.5 | vs BSE 543594 |
| Ganga Pharmaceuticals | 7 | 78.1 | 2.9 | 1.3 | 0.13 | 0.0 | 3 | 0 | 9.8 | 40.0 | vs BSE 543594 |
| Peer median | 13 | 22.3 | 6.6 | 4.6 | 0.17 | 0.0 | 7 | 0 | −8.8 | −57.5 |
Listed companies closest to Dipna Pharmachem in Pharmaceuticals include Centuple Global, Colinz Laboratories, Zenith Health Care, Starsource Multitrade, Desh Rakshak Aushdhalaya, Beryl Drugs, Unjha Formulations, ORTIN GLOBAL.
Centuple Global, with a market cap of ₹17.59 Cr.
Dipna Pharmachem trades at a P/E of 4.2; the median of its peer set is 22.3. A P/E above or below the median is a description, not a judgement on value.
Dipna Pharmachem's return on capital employed is 8.1%, above the peer median of 6.6%.